OBJECTIVE: To investigate the molecular genetic mechanism of Charcot- Marie-Tooth (CMT) disease in a pedigree. METHODS: Genomic DNA was extracted from the peripheral blood of the family members of a pedigree with autosomal dominant CMT disease, and 65 candidate genes of the proband were screened using target exon capture and the next generation sequencing, and the suspicious genes were verified using Sanger sequencing. PolyPhen-2, PROVEAN and SIFT software were used to predict the function of the mutant genes, and PyMOL-1 software was used to simulate the mutant protein structure. RESULTS: A heterozygous missense mutation [c.371A>G (p.Y124C)] was detected in exon 3 of GDAP1 gene of the proband. This heterozygous mutation was also detected in both the proband's mother and her brother, but not in her father. Multiple sequence alignment analysis showed that tyrosine at codon 124 of GDAP1 protein was highly conserved. All the 3 prediction software predicted that the mutation was harmful. Molecular structure simulation showed a weakened interaction force between the amino acid residues at codon 124 and the surrounding amino acid residues to affect the overall stability of the protein. CONCLUSIONS: The mutation of GDAP1 gene may be related to the pathogenesis of autosomal dominant AD-CMT in this pedigree. The newly discovered c.371A>G mutation (p.Y124C) expands the mutation spectrum of GDAP1 gene, but further study is needed to clarify the underlying pathogenesis.
OBJECTIVE: To investigate the molecular genetic mechanism of Charcot- Marie-Tooth (CMT) disease in a pedigree. METHODS: Genomic DNA was extracted from the peripheral blood of the family members of a pedigree with autosomal dominant CMT disease, and 65 candidate genes of the proband were screened using target exon capture and the next generation sequencing, and the suspicious genes were verified using Sanger sequencing. PolyPhen-2, PROVEAN and SIFT software were used to predict the function of the mutant genes, and PyMOL-1 software was used to simulate the mutant protein structure. RESULTS: A heterozygous missense mutation [c.371A>G (p.Y124C)] was detected in exon 3 of GDAP1 gene of the proband. This heterozygous mutation was also detected in both the proband's mother and her brother, but not in her father. Multiple sequence alignment analysis showed that tyrosine at codon 124 of GDAP1 protein was highly conserved. All the 3 prediction software predicted that the mutation was harmful. Molecular structure simulation showed a weakened interaction force between the amino acid residues at codon 124 and the surrounding amino acid residues to affect the overall stability of the protein. CONCLUSIONS: The mutation of GDAP1 gene may be related to the pathogenesis of autosomal dominant AD-CMT in this pedigree. The newly discovered c.371A>G mutation (p.Y124C) expands the mutation spectrum of GDAP1 gene, but further study is needed to clarify the underlying pathogenesis.
Authors: Dagmara Kabzińska; Katarzyna Kotruchow; Joanna Cegielska; Irena Hausmanowa-Petrusewicz; Andrzej Kochański Journal: Acta Biochim Pol Date: 2014-10-22 Impact factor: 2.149
Authors: Rebecca Noack; Svenja Frede; Philipp Albrecht; Nadine Henke; Annika Pfeiffer; Katrin Knoll; Thomas Dehmel; Gerd Meyer Zu Hörste; Mark Stettner; Bernd C Kieseier; Holger Summer; Stefan Golz; Andrzej Kochanski; Martina Wiedau-Pazos; Susanne Arnold; Jan Lewerenz; Axel Methner Journal: Hum Mol Genet Date: 2011-09-28 Impact factor: 6.150
Authors: Lidiane Carine Lima Santos Barreto; Fernanda Santos Oliveira; Paula Santos Nunes; Iandra Maria Pinheiro de França Costa; Catarina Andrade Garcez; Gabriel Mattos Goes; Eduardo Luis Aquino Neves; Jullyana de Souza Siqueira Quintans; Adriano Antunes de Souza Araújo Journal: Neuroepidemiology Date: 2016-02-06 Impact factor: 3.282
Authors: M Zimoń; J Baets; G M Fabrizi; E Jaakkola; D Kabzińska; J Pilch; A B Schindler; D R Cornblath; K H Fischbeck; M Auer-Grumbach; C Guelly; N Huber; E De Vriendt; V Timmerman; U Suter; I Hausmanowa-Petrusewicz; A Niemann; A Kochański; P De Jonghe; A Jordanova Journal: Neurology Date: 2011-07-13 Impact factor: 9.910